Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
Follow HSIC
Alert me
Henry Schein, Inc. (HSIC) Current ratio
Henry Schein, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.3×, down 0.1× from fiscal 2025 (1.4×). Over the past ten years it has ranged from 1.3× (fiscal 2018) to 1.8× (fiscal 2022); the current reading is higher than 18% of that period. That is above the Medical Distribution industry median of 1.0× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.4× | (2.68%) |
| FY2024 | 1.4× | (15.05%) |
| FY2023 | 1.7× | (6.71%) |
| FY2022 | 1.8× | 7.62% |
| FY2021 | 1.7× | 0.34% |
| FY2020 | 1.7× | 4.91% |
| FY2019 | 1.6× | 22.03% |
| FY2018 | 1.3× | (10.19%) |
| FY2017 | 1.4× | 0.26% |
| FY2016 | 1.4× | (4.28%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.3× | 0.65% |
| Jun 2026 | 1.3× | (3.29%) |
| Mar 2026 | 1.4× | (1.39%) |
| Dec 2025 | 1.4× | (0.92%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| FOCL FocalTherics compare | 1.6× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| HSIC Henry Schein, Inc. | 1.3× |
| YI 111, Inc. Sponsored ADR compare | 1.1× |
| COSM Cosmos Health Inc. compare | 1.1× |
| COR Cencora, Inc. compare | 0.9× |
| MCK McKesson Corporation compare | 0.9× |
| CAH Cardinal Health, Inc. compare | 0.9× |
| ACH Accendra Health, Inc. compare | 0.4× |
| Medical Distribution industry median | 1.0× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement